The authors examine the potential areas of concern during the postpartum period, as well as practical approaches to differential diagnosis and treatment.
Unsuccessful fertility treatment takes a toll on both partners, and knowing their mental health history can help predict depression risk.
An intensive in-home program aimed at pregnant teens at risk for drug use and depression, specifically American Indian teens, proves successful.
More than a third of women consider ob/gyns their primary care providers. To better meet the needs of their patients, one ob/gyn clinic offered different treatments for depression and compared the results.
In this podcast, B. Andrew Farah, MD, looks at shortcomings of current therapy that make treatment-resistant depression so common, offers insights into the genetic underpinnings of TRD, and focuses on a new treatment paradigm.
Antidepressant use in pregnancy increases the risk of preterm birth. However, untreated depression is serious, and the needs of the mother must come first.
Nurse-delivered interventions that combined psychoeducation with supportive attention may help improve mood in patients in whom cancer has been newly diagnosed.
For women undergoing fertility treatments, the use of selective serotonin reuptake inhibitors use may decrease pregnancy rates and increase miscarriage rates.
Each year, between 300 and 400 physicians in the United States die by suicide, and physicians seek care for depression and other mood disorders at lower rates than the general public.
More than one third of women in the United States will experience some form of intimate partner violence (IPV) in their lifetime. The consequences of IPV can be lifelong and include emotional trauma, long-term physical impairment, chronic health problems, and even death.